SAM #75F40126SSN134795

FDA Seeks Lonza 4D or Equivalent Nucleofection System with Installation and Training

The FDA Center for Biologics Evaluation and Research (CBER) is seeking information from small business sources for a laboratory nucleofection system. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Biologics Evaluation and Research (CBER) - Office of Acquisitions and Grants Services (OAGS) - OEM Highlight: - Lonza is the specified OEM for the 4D Nucleofection System; equivalent systems from other manufacturers are also considered - Products Requested: - Nucleofection System (Lonza 4D or equal) - Quantity: 1 - Capable of delivering DNA, RNA, and proteins into cell lines and human primary cells - Must use conductive polymer (metal-free) electrodes - Achieve up to 90% post-transfection cell viability - Specialized substrate-driving electrical waveform - Onboard software database with factory-preprogrammed pulse protocols for primary human dendritic cells - Includes all hardware, components, instruments, computers, software, supplies, accessories, and standard kits for installation, start-up, and qualification tests - Newly manufactured, turn-key solution - Services Requested: - Delivery, installation, and training for 3-5 users - Installation by factory certified personnel - On-site training covering system operations, calibration, optimization, troubleshooting, and basic maintenance - Minimum one-year warranty including technical support - Unique Requirements: - Metal-free electrodes - High cell viability (up to 90%) - Specialized software and preprogrammed protocols for primary human dendritic cells - On-site training and warranty support - Delivery, installation, and training to be completed within 120 days of contract award

Description

See attached Sources Sought Notice (SSN) for a Lonza 4D or equal nucleofection system

View original listing